FDA
approval
· 2018-06-20
FDA Approved: TYMLOS — Supplemental Application (Radius Health, Inc.)
Summary
The FDA approved a supplemental application for TYMLOS (abaloparatide) by Radius Health, Inc. This action reflects an approved supplemental submission for the p…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TYMLOS (ABALOPARATIDE)